<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ACRX</title>
    <link />
    <description>Headlines for AcelRx Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Why AcelRx Pharmaceuticals Shares Spiked Temporarily</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/21/why-acelrx-pharmaceuticals-shares-spiked-temporari/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 21 May 2013 14:47:00 GMT</pubDate>
    </item>
    <item>
      <title>U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130521-000197&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Tue, 21 May 2013 08:59:00 GMT</pubDate>
    </item>
    <item>
      <title>Pre-Market Most Active for May 21, 2013 :  JASO, MSFT, SDBT, AMAT, ACRX, CSIQ</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/premarket-most-active-for-may-21-2013-jaso-msft-sdbt-amat-acrx-csiq-cm247402.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 21 May 2013 08:39:53 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Top Pre-Market Gainers</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3606961/benzingas-top-pre-market-gainers.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 21 May 2013 08:10:11 GMT</pubDate>
    </item>
    <item>
      <title>AcelRx Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1416561-acelrx-pharmaceuticals-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 08 May 2013 19:38:05 GMT</pubDate>
    </item>
    <item>
      <title>AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3552053/acelrx-pharmaceuticals-presents-positive-clinical-data-for-the-sufentanil-nanotab.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 02 May 2013 07:31:32 GMT</pubDate>
    </item>
    <item>
      <title>Top-line Data Show AcelRx Pharmaceuticals' ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3523894/top-line-data-show-acelrx-pharmaceuticals-arx-04-achieves-primary-endpoint-in-dos.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 24 Apr 2013 07:30:55 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/04/13/this-week-in-biotech-23/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 13 Apr 2013 14:20:00 GMT</pubDate>
    </item>
    <item>
      <title>4 Biotech Stocks Under $10 Making Big Moves</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/4-biotech-stocks-under-10-making-big-moves.html-0.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 09 Apr 2013 14:11:00 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Jefferies Initiates AcelRx Pharmaceuticals with Buy on Expected FDA Approval for ARX-01</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/04/3478414/update-jefferies-initiates-acelrx-pharmaceuticals-with-b.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 08 Apr 2013 09:43:08 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Top Initiations</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/initiation/13/04/3478208/benzingas-top-initiations.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 08 Apr 2013 09:01:16 GMT</pubDate>
    </item>
    <item>
      <title>Obagi Medical Products Acquired Wednesday, These Biotechs May Be Next</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1291261-obagi-medical-products-acquired-wednesday-these-biotechs-may-be-next.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 21 Mar 2013 04:47:45 GMT</pubDate>
    </item>
    <item>
      <title>AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1284291-acelrx-pharmaceutical-s-potential-billion-dollar-treatment-under-the-radar.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 19 Mar 2013 08:32:00 GMT</pubDate>
    </item>
    <item>
      <title>AcelRx Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1268581-acelrx-pharmaceuticals-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 12 Mar 2013 19:13:04 GMT</pubDate>
    </item>
    <item>
      <title>After-Hours Earnings Report for March 12, 2013 :  KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN,</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/afterhours-earnings-report-for-march-12-2013-kw-dole-acad-gca-gnmk-avid-wsr-ktos-gern-acrx-fold-gcap-cm226423.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 12 Mar 2013 14:00:05 GMT</pubDate>
    </item>
    <item>
      <title>Small Pharmas With Imminent Catalysts For March 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1263891-small-pharmas-with-imminent-catalysts-for-march-2013.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 11 Mar 2013 15:26:30 GMT</pubDate>
    </item>
    <item>
      <title>AcelRx Pharmaceuticals' CEO Presents at Cowen and Company 33rd Annual Health Care Conference - Confe</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1252391-acelrx-pharmaceuticals-ceo-presents-at-cowen-and-company-33rd-annual-health-care-conference-conference-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 06 Mar 2013 14:46:06 GMT</pubDate>
    </item>
    <item>
      <title>U.S. Stock Futures Rally; Dow Set To Open Above Record High</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130305-000283&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Tue, 05 Mar 2013 09:14:00 GMT</pubDate>
    </item>
    <item>
      <title>AcelRx Pharma Offers Updates on Clinical Trials</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3343660/acelrx-pharma-offers-updates-on-clinical-trials.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 19 Feb 2013 07:40:05 GMT</pubDate>
    </item>
    <item>
      <title>3 Speculative Healthcare Companies With High Levels Of Insider Ownership</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1201941-3-speculative-healthcare-companies-with-high-levels-of-insider-ownership.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 19 Feb 2013 07:19:39 GMT</pubDate>
    </item>
  </channel>
</rss>
